|
Loading...
| ||||||||||||||
Recent Publications by GSK: |  | |
| [Assessment of the simplified versions of the Asthma Control Questionnaire.]
BACKGROUND AND OBJECTIVE: The aim of this study was to assess the... | Departamento Medico. GlaxoSmithKline SA. Tres Cantos. Madrid. Espana. | Med Clin (Barc). 2008 Sep 20;131(9):326-332. |
| Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1.
We describe robust chemical approaches toward putative CCR5 scaffolds... | Infectious Diseases Center for Excellence in Drug Discovery, Molecular | J Med Chem. 2008 Sep 24.
DOI Direct Link |
| PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home.
BACKGROUND: The identification of small molecule agonists for the nuclear... | GlaxoSmithKline, Inc., 5 Moore Drive, Research Triangle Park, NC 27709, | Expert Opin Investig Drugs. 2008 Oct;17(10):1465-71.
DOI Direct Link |
| Microbiology. Desperately seeking new antibiotics.
BACKGROUND: The identification of small molecule agonists for the nuclear... | Antibacterial Disease Performance Unit, Infectious Diseases Center of | Science. 2008 Sep 19;321(5896):1644-5.
DOI Direct Link |
| Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]o xy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.
Overexpression of AKT has an antiapoptotic effect in many cell types, and... | Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 | J Med Chem. 2008 Sep 25;51(18):5663-79.
DOI Direct Link |
GSK Patents: |  |
| US Patent No. | Title |
| 7400079 | Ultrasonic probe |
| 7388489 | System and method for managing data on an RFID tag associated with a product |
| 7367585 | Inflating device for an air bag of a vehicle |
| 4650574 | Apparatus for the separation of solutions by pervaporation |